Literature DB >> 17583369

Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life.

Ayumi Sato1, Sung Won Choi, Miwa Hirai, Asako Yamayoshi, Rui Moriyama, Takeshi Yamano, Motoki Takagi, Arihiro Kano, Akira Shimamoto, Atsushi Maruyama.   

Abstract

Delivery systems of small interfering RNA (siRNA) are the key to siRNA therapeutic application. In this study, we prepared and evaluated a series of cationic comb-type copolymers (CCCs) possessing a polycationic backbone (less than 30 weight (wt) %) and abundant water-soluble side chains (more than 70 wt.%) as a siRNA carrier with prolonged blood circulation time. Markedly, the CCC with the higher side chain content (10 wt.% PLL and 90 wt.% PEG) showed stronger interaction with siRNA than that with the lower content (30 wt.% PLL and 70 wt.% PEG), suggesting that highly dense PEG brush reinforces interpolyelectrolyte complex between the PLL backbone and siRNA. The siRNA complexed with the CCC was resistant to nucleases in 90% plasma for 24 h in vitro. The CCC having the higher side chain content increased circulation time of siRNA in mouse bloodstream by 100-fold. Surprisingly, even when the CCC and siRNA were separately injected into mouse at 20 min interval, blood circulation of post-injected siRNA was significantly increased. These results imply that the CCC has higher selectivity in its ionic interaction with siRNA than other anionic substances in blood stream. To our knowledge, this is the first example of a polyplex carrier that prolongs blood circulation time of unmodified siRNA without resource-consuming preparation process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17583369     DOI: 10.1016/j.jconrel.2007.04.018

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

1.  Duplex end breathing determines serum stability and intracellular potency of siRNA-Au NPs.

Authors:  Pinal C Patel; Liangliang Hao; Weng Si Au Yeung; Chad A Mirkin
Journal:  Mol Pharm       Date:  2011-06-28       Impact factor: 4.939

2.  Hydrolytic charge-reversal of PEGylated polyplexes enhances intracellular un-packaging and activity of siRNA.

Authors:  Thomas A Werfel; Corban Swain; Christopher E Nelson; Kameron V Kilchrist; Brian C Evans; Martina Miteva; Craig L Duvall
Journal:  J Biomed Mater Res A       Date:  2016-01-11       Impact factor: 4.396

Review 3.  Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy.

Authors:  Yunching Chen; Leaf Huang
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

Review 4.  New short interfering RNA-based therapies for glomerulonephritis.

Authors:  Hideki Shimizu; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

5.  New Techniques to Assess In Vitro Release of siRNA from Nanoscale Polyplexes.

Authors:  Bettina Krieg; Markus Hirsch; Erik Scholz; Lutz Nuhn; Ilja Tabujew; Heiko Bauer; Sandra Decker; Andriy Khobta; Manfred Schmidt; Wolfgang Tremel; Rudolf Zentel; Kalina Peneva; Kaloian Koynov; A James Mason; Mark Helm
Journal:  Pharm Res       Date:  2014-12-09       Impact factor: 4.200

6.  Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.

Authors:  Samantha M Sarett; Thomas A Werfel; Irene Chandra; Meredith A Jackson; Taylor E Kavanaugh; Madison E Hattaway; Todd D Giorgio; Craig L Duvall
Journal:  Biomaterials       Date:  2016-04-21       Impact factor: 12.479

7.  Combinatorial optimization of PEG architecture and hydrophobic content improves ternary siRNA polyplex stability, pharmacokinetics, and potency in vivo.

Authors:  Thomas A Werfel; Meredith A Jackson; Taylor E Kavanaugh; Kellye C Kirkbride; Martina Miteva; Todd D Giorgio; Craig Duvall
Journal:  J Control Release       Date:  2017-03-31       Impact factor: 9.776

8.  Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo.

Authors:  Christopher E Nelson; James R Kintzing; Ann Hanna; Joshua M Shannon; Mukesh K Gupta; Craig L Duvall
Journal:  ACS Nano       Date:  2013-09-23       Impact factor: 15.881

9.  Dual carrier-cargo hydrophobization and charge ratio optimization improve the systemic circulation and safety of zwitterionic nano-polyplexes.

Authors:  Meredith A Jackson; Sean K Bedingfield; Fang Yu; Mitchell E Stokan; Rachel E Miles; Elizabeth J Curvino; Ella N Hoogenboezem; Rachel H Bonami; Shrusti S Patel; Peggy L Kendall; Todd D Giorgio; Craig L Duvall
Journal:  Biomaterials       Date:  2018-11-10       Impact factor: 12.479

10.  Self-assembled particles of N-phthaloylchitosan-g-polycaprolactone molecular bottle brushes as carriers for controlled release of indometacin.

Authors:  Youju Huang; Liangbin Li; Yue'e Fang
Journal:  J Mater Sci Mater Med       Date:  2009-09-26       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.